doi: 10.2337/dc07-zb09.
The Avandia debate
Affiliations
- PMID: 17726191
- DOI: 10.2337/dc07-zb09
Item in Clipboard
The Avandia debate
Diabetes Care.
2007 Sep.
No abstract available
Similar articles
-
The Avandia debate: an unhappy conclusion.J Diabetes. 2010 Dec;2(4):221-2. doi: 10.1111/j.1753-0407.2010.00096.x. J Diabetes. 2010. PMID: 20923505 No abstract available.
-
Outlook on diabetes drug less than rosy. Early work suggests that rosiglitazone (Avandia) may not be best for the heart.Harv Heart Lett. 2007 Aug;17(12):1-2. Harv Heart Lett. 2007. PMID: 17717888 No abstract available.
-
Heart-stopping news. The diabetes drug Avandia is under fire: what you should know. Interview by Avery Comarow.US News World Rep. 2007 Jun 4;142(20):64. US News World Rep. 2007. PMID: 17632813 No abstract available.
-
The rosiglitazone meta-analysis.Rev Cardiovasc Med. 2007 Spring;8(2):123-6. Rev Cardiovasc Med. 2007. PMID: 17603430 Review. No abstract available.
-
Lessons from the Avandia controversy: a new paradigm for the development of drugs to treat type 2 diabetes.Diabetes Care. 2007 Dec;30(12):3141-4. doi: 10.2337/dc07-1908. Diabetes Care. 2007. PMID: 18042753 Review. No abstract available.
Cited by
-
Updating insights into rosiglitazone and cardiovascular risk through shared data: individual patient and summary level meta-analyses.BMJ. 2020 Feb 5;368:l7078. doi: 10.1136/bmj.l7078. BMJ. 2020. PMID: 32024657 Free PMC article.
-
Diabetes Drugs and Cardiovascular Safety.Endocrinol Metab (Seoul). 2016 Jun;31(2):239-44. doi: 10.3803/EnM.2016.31.2.239. Epub 2016 Jun 10. Endocrinol Metab (Seoul). 2016. PMID: 27302713 Free PMC article. Review.
-
Redefining the role of thiazolidinediones in the management of type 2 diabetes.Vasc Health Risk Manag. 2009;5(1):141-51. doi: 10.2147/vhrm.s4664. Epub 2009 Apr 8. Vasc Health Risk Manag. 2009. PMID: 19436665 Free PMC article. Review.
-
Diabetes treatment and cardiovascular safety.Diabetes Care. 2011 Apr;34(4):e36-42. doi: 10.2337/dc11-0201. Diabetes Care. 2011. PMID: 21447655 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
